Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/16/17
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/15/17
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/28/17
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 11/05/20
End: 12/31/23
Due: 12/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Swiss Autoimmune Hepatitis Cohort Study | NCT03146884 | Fondazione Epatocentro Ticino | user2@example.com | None | 2017-02-16 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Swiss Primary Biliary Cholangitis Cohort Study | NCT03146910 | Fondazione Epatocentro Ticino | user2@example.com | None | 2017-02-15 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Swiss Primary Sclerosing Cholangitis Cohort Study | NCT03146936 | Fondazione Epatocentro Ticino | user2@example.com | None | 2017-02-28 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Methylene Blue Treatment of COVID-19 | NCT04635605 | Fondazione Epatocentro Ticino | user2@example.com | None | 2020-11-05 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |